 |
Video: What is a Stock Split?
|
 |
Miragen Therapeutics is a clinical-stage biopharmaceutical company discovering and developing proprietary RNA-targeted therapeutics with a specific focus on microRNAs and their role in certain diseases. Co. has three product candidates, cobomarsen, remlarsen and MRG-110, in clinical development. Cobomarsen is an inhibitor of miR-155, which is a microRNA that is found at abnormally high levels in malignant cells of several blood cancers. Remlarsen is a replacement for miR-29, a microRNA that is found at abnormally low levels in a number of pathological fibrotic conditions. MRG-110 is an inhibitor of miR-92, a microRNA expressed in endothelial cells. According to our MGEN split history records, Miragen Therapeutics has had 1 split. |
|
 |

Miragen Therapeutics (MGEN) has 1 split in our MGEN split history database. The split for MGEN took place on May 16, 2001. This was a 11 for 10 split, meaning for each 10 shares of MGEN owned pre-split, the shareholder now owned 11 shares. For example, a 1000 share position pre-split, became a 1100 share position following the split.
When a company such as Miragen Therapeutics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the MGEN split history from start to finish, an original position size of 1000 shares would have turned into 1100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Miragen Therapeutics shares, starting with a $10,000 purchase of MGEN, presented on a split-history-adjusted basis factoring in the complete MGEN split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/18/2014 |
|
End date: |
12/06/2019 |
|
Start price/share: |
$9.09 |
|
End price/share: |
$0.58 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-93.64% |
|
Average Annual Total Return: |
-39.57% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$635.60 |
|
Years: |
5.47 |
|
|
 |
Date |
Ratio |
05/16/2001 | 11 for 10 |
|
 |